Elevate Uranium Valuation
| ELVUF Stock | USD 0.17 0.01 5.56% |
Elevate Uranium seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Elevate Uranium from reviewing the firm fundamentals such as Shares Owned By Insiders of 16.66 %, current valuation of 59.41 M, and Shares Owned By Institutions of 10.13 % as well as analyzing its technical indicators and probability of bankruptcy. . In general, most investors advise locking in undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will submerge.
Overvalued
Today
Please note that Elevate Uranium's price fluctuation is out of control at this time. Calculation of the real value of Elevate Uranium is based on 3 months time horizon. Increasing Elevate Uranium's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Elevate otc stock is determined by what a typical buyer is willing to pay for full or partial control of Elevate Uranium. Since Elevate Uranium is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Elevate OTC Stock. However, Elevate Uranium's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.17 | Real 0.16 | Hype 0.17 | Naive 0.16 |
The real value of Elevate OTC Stock, also known as its intrinsic value, is the underlying worth of Elevate Uranium OTC Stock, which is reflected in its stock price. It is based on Elevate Uranium's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Elevate Uranium's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Elevate Uranium helps investors to forecast how Elevate otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Elevate Uranium more accurately as focusing exclusively on Elevate Uranium's fundamentals will not take into account other important factors: Elevate Uranium Total Value Analysis
Elevate Uranium is currently anticipated to have takeover price of 59.41 M with market capitalization of 84.11 M, debt of 177.27 K, and cash on hands of 15.81 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Elevate Uranium fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
59.41 M | 84.11 M | 177.27 K | 15.81 M |
Elevate Uranium Investor Information
About 17.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.01. Elevate Uranium had not issued any dividends in recent years. The entity had 1:100 split on the 5th of November 2014. Elevate Uranium is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Elevate Uranium Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Elevate Uranium has an asset utilization ratio of 0.6 percent. This implies that the OTC Stock is making $0.006045 for each dollar of assets. An increasing asset utilization means that Elevate Uranium is more efficient with each dollar of assets it utilizes for everyday operations.Elevate Uranium Ownership Allocation
Elevate Uranium holds a total of 275.5 Million outstanding shares. Elevate Uranium shows 16.66 percent of its outstanding shares held by insiders and 10.13 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Elevate Uranium Profitability Analysis
The company reported the revenue of 116.86 K. Net Loss for the year was (5.73 M) with profit before overhead, payroll, taxes, and interest of 116.86 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Elevate Uranium's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Elevate Uranium and how it compares across the competition.
About Elevate Uranium Valuation
The otc valuation mechanism determines Elevate Uranium's current worth on a weekly basis. Our valuation model uses a comparative analysis of Elevate Uranium. We calculate exposure to Elevate Uranium's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Elevate Uranium's related companies.Elevate Uranium Ltd engages in the exploration and evaluation of uranium deposits. Elevate Uranium Ltd was incorporated in 1978 and is headquartered in West Perth, Australia. Elevate Uranium operates under Uranium classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Elevate Uranium's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Elevate Uranium's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Elevate Uranium's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Elevate Uranium's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Elevate Uranium's revenue streams: Identify Elevate Uranium's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Elevate Uranium's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Elevate Uranium's growth potential: Evaluate Elevate Uranium's management, business model, and growth potential.
- Determine Elevate Uranium's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Elevate Uranium's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Elevate Uranium Growth Indicators
Investing in growth stocks can be very risky. If the company such as Elevate Uranium does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 275.5 M | |
| Retained Earnings | -60.6 M |
Complementary Tools for Elevate OTC Stock analysis
When running Elevate Uranium's price analysis, check to measure Elevate Uranium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevate Uranium is operating at the current time. Most of Elevate Uranium's value examination focuses on studying past and present price action to predict the probability of Elevate Uranium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevate Uranium's price. Additionally, you may evaluate how the addition of Elevate Uranium to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |